FDA Recall Video

Did something similar happen to you or a loved one?
If you are a journalist contact me for an interview.
If you are a law enforcement officer please contact me.


Call Stephen Horrillo at 954-943-3479 or Email:

Billionaire CEO
Device Makers Profit
The Invisible Killer
Dr. Dworkin Medicare
FDA Recall Video
RAS Studies
Endovascular Today
DOJ Is Prosecuting
American Bar Assn
Risks & Complications
Photos of Victim

Watch the FDA Video Warning on Using
a Biliary Stent in the Vascular System
(Video, print, and e-mail functions)


Skip NavigationFDA Logo links to FDA home pageCenter for Devices and Radiological Health, U.S. Food and Drug AdministrationHHS Logo links to Department of Health and Human Services website

FDA Home Page | CDRH Home Page | Search | CDRH A-Z Index | Contact CDRH U.S. Food and Drug Administration Center for Devices and Radiological Health
horizonal rule

Medical Device Recalls
Class 1 Recall: Biliary Stents Instructions for Use

Date Recall
May 4, 2004
PRECISE® RX Nitinol Stent Transhepatic Biliary System
Biliary stents are permanently implanted flexible tubular devices intended for use to treat bile duct obstruction due to malignancies. They function to drain the biliary tract and to keep the bile duct open. Uses outside of the biliary tract, i.e., in the cardiovascular or other systems, have not been cleared by the FDA.
Recalling Firm:
Cordis Corporation
14201 NW 60th Ave
Miami Lakes, FL 33014-2802
Reason for Recall:
Some physicians use this device for vascular use. This use has not been cleared by the FDA. When used this way, air may be introduced into the patient via the stent system causing serious problems including coma, seizure and stroke. There have been nine patient injuries due to air embolism and seven incidents of malfunction in connection with the use of this system outside of its approved indications. Cordis is recalling its revised instructions for use and strongly recommends that physicians limit the use of the PRECISE RX Stent to FDA-approved uses only.
Public Contact:
Hal Delgado
Executive Director, Quality Assurance
FDA District:
FDA Comment:
Physicians are informed in the current labeling warning statement that the “safety and effectiveness for use in the vascular system have not been established.” Class I recalls are the most serious type of recall and involve situations where there is a reasonable probability that use of the product will cause serious injury or death.
  For additional information on this product recall, see the Cordis Corporation press release at: http://www.cordis.com/active/crdus/en_US/html/cordis/downloads/press/